Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DAS Evaluation of RA Activity in Patients Treated With Tocilizumab

NCT01388309 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01388309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01388309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DAS Evaluation of RA Activity in Patients Treated With Tocilizumab
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
March 31, 2013
Enrollment
64 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis